What are the available strengths of Tretinoin (all-trans retinoic acid) cream?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tretinoin Cream Available Strengths

Tretinoin cream is available in three FDA-approved strengths: 0.025%, 0.05%, and 0.1%, formulated in a hydrophilic cream vehicle. 1

FDA-Approved Formulations

Tretinoin is available in two primary topical formulations:

Cream Formulations

  • 0.025% tretinoin cream 1
  • 0.05% tretinoin cream 1, 2
  • 0.1% tretinoin cream 1, 3

Gel Formulations

  • 0.01% tretinoin gel 1
  • 0.025% tretinoin gel 1
  • 0.04% tretinoin gel microsphere (TGM) 4
  • 0.1% tretinoin gel microsphere (TGM) 4

Clinical Context for Strength Selection

For Acne Vulgaris

  • All three cream strengths (0.025%, 0.05%, 0.1%) are effective for comedonal acne and serve as the core of topical acne therapy 5
  • The American Academy of Dermatology recognizes tretinoin as ideal for comedonal acne and, when combined with other agents, for all acne variants 5, 6
  • Lower strengths like 0.025% provide effective treatment while potentially minimizing irritation 6

For Photodamaged Skin

  • 0.05% tretinoin emollient cream demonstrated significant improvement in fine wrinkling, surface roughness, and mottled hyperpigmentation in 48-week studies 2
  • 0.1% tretinoin cream has been used extensively with liberal daily application showing the most success for photoaging 3
  • 0.01% tretinoin cream also showed effectiveness for photodamage with potentially better tolerability 2

For Actinic Keratoses

  • 0.3% tretinoin ointment achieved 55% complete clearance versus 35% with 0.1% strength, demonstrating a dose-response relationship 5
  • 0.05% tretinoin used once or twice daily showed 47% reduction in facial actinic keratoses after 15 months 5
  • 0.1% tretinoin showed modest efficacy with 30.3% reduction after 16 weeks of twice-daily use 5

Important Clinical Considerations

Tolerability varies with concentration: Higher strengths provide greater efficacy but increase the risk of cutaneous irritation including erythema, peeling, dryness, burning, and itching 4

Formulation matters: The gel microsphere formulations were specifically developed to minimize irritation while maintaining efficacy 4

All tretinoin formulations are pregnancy category C and require appropriate counseling 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.